Background: Although imipenem/cilastatin (IMI/CIL) has demonstrated favorable therapeutic efficacy against various infections, the incidence of potential adverse events (AEs) has escalated in parallel ...

A retrospective study of patients with carbapenem non-susceptible infections and limited treatment options at 24 US hospitals ...

Keywords: imipenem, population pharmacokinetics, dosing optimization, elderly patients, Monte Carlo Citation: Wang J, Fang Q, Luo X, Jin L and Zhu H (2025) Corrigendum: Population pharmacokinetics and ...

Yesterday during President Donald Trump's first cabinet meeting, Health and Human Services (HHS) Secretary Robert F. Kennedy ...

merepenem and imipenem/cilistatin). Of these alternative choices, we recommend ertapenem owing to our ability to dose it once a day. Finally, for those women with an immediate hypersensitivity to ...

The high incidence of culture-positive sepsis, case-fatality rates, and multidrug resistance among common pathogens underscores an urgent need to strengthen infection prevention and control practices, ...

A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) among diarrheagenic Escherichia coli (E. coli), a major foodborne pathogen ...

Notably, resistance to ampicillin was found in 68.2% of isolates, while resistance to imipenem remained relatively low at 1.6%. Additionally, resistance to cefoxitin and chloramphenicol ...

Expert Rev Anti Infect Ther. 2012;10(8):917-934. Figure 1 represents the number of citations found in the PubMed database from 1960 to the middle of 2011 using either the search phrase 'colistin ...